FDA issued a Warning Letter to Celltex Therapeutics Corporation on 9/24/2012 as a result of this inspection.
483 Celltex Therapeutics Apr 2012

483 Celltex Therapeutics Apr 2012

Linda Hoover FDA, Joel Martinez FDA$119.00 - Available Now

FDA investigators audited the Celltex Therapeutics - Sugar Land, TX, United States facility and issued inspectional observations (via FDA 483) on 27 Apr 2012.

Product details

  • Category: Biologics
  • Inspection end: 27 Apr 2012
  • Location: Sugar Land, United States
  • FEI: 3009499974
Add To Cart
Celltex Therapeutics FDA inspection 483 Apr 2012Add To Cart